Christopher Bogart Insider Profile

4 Followers
Christopher Bogart, Senior Officer at InMed Pharmaceuticals, holds 7.29M shares in InMed Pharmaceuticals (Ticker: INM), holds 5.99M shares in Choom Holdings (Ticker: CHOOF), holds 1.53M shares in Corex Gold (Ticker: TSE:CGE). Most recently, Christopher Bogart ― shares of InMed Pharmaceuticals on ― for an estimated value of ―.
tipranks
Christopher Bogart

Christopher Bogart
InMed Pharmaceuticals (INM)
Senior Officer

Ranked #89,056 out of 98,042 Corporate Insiders

Profitable Transactions

20%
5 out of 25 Profitable Transactions

Average Return

-15.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
96.43%
3.57%
A breakdown of Christopher Bogart's holdings

Insider Roles

InMed Pharmaceuticals
(INM)
Senior Officer
Choom Holdings
(CHOOF)
President
Roles that Christopher Bogart holds in companies

Most Profitable Insider Trade

Stock:
Choom Holdings
(CHOOF)
Rating:Informative Buy
Date:Mar 21, 2016 - Mar 21, 2017
Return:+276.90%
The most profitable trade made by Christopher Bogart

Christopher Bogart's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
InMed Pharmaceuticals
Senior Officer
$2.10M
Choom Holdings
Aug 19, 2021
President
Informative Buy
77.38K
$77.83K
CGE
Corex Gold
May 23, 2012
Informative Buy
12.50K
C$206.00K
List of latest transactions for each holding click on a transaction to see Christopher Bogart's performance on stock

Christopher Bogart insider profile FAQ

What is the percentage of profitable transactions made by Christopher Bogart?
The percentage of profitable transactions made by Christopher Bogart is 20%.
    What is the average return per transaction made by Christopher Bogart?
    The average return per transaction made by Christopher Bogart is -15.90%.
      What stocks does Christopher Bogart hold?
      Christopher Bogart holds: INM, CHOOF, TSE:CGE stocks.
        What was Christopher Bogart’s latest transaction?
        Christopher Bogart latest transaction was an Uninformative Buy of ―.
          What was Christopher Bogart's most profitable transaction?
          Christopher Bogart’s most profitable transaction was an Informative Buy of CHOOF stock on March 21, 2016. The return on the trade was 276.90%.
            What is Christopher Bogart's role in InMed Pharmaceuticals?
            Christopher Bogart's role in InMed Pharmaceuticals is Senior Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.